Chinese Firm Targets Key GaN Patent
Ongoing Patent Disputes in U.S. and Germany
![]() |
(Source:Innoscience) |
Chinese semiconductor company Innoscience has filed a petition for Inter Partes Review (IPR) with the Patent Trial and Appeal Board (PTAB) to invalidate a patent owned by German semiconductor giant Infineon.
The IPR targets one of four patents Infineon claims Innoscience has infringed. The two companies are already embroiled in ongoing patent litigation concerning gallium nitride (GaN) technology in both the U.S. and Germany.
Infineon initially filed suit against Innoscience in the Northern District of California in March 2024, accusing the Chinese firm of infringing at least one patent—U.S. Patent No. 9,899,481. The case involves Infineon Technologies Austria AG as the plaintiff and Innoscience's Zhuhai, Suzhou, and U.S. units as defendants.
![]() |
(Source: U.S. District Court for the Northern District of California) |
Innoscience's IPR petition, filed in June 2024, asserts that Infineon's '481 patent is invalid based on seven prior art references and thirteen grounds of invalidity, arguing that all 17 claims of the patent are unpatentable.
In July 2024, Infineon added three more patents to the California lawsuit—U.S. Patents 8,686,562, 9,070,755, and 8,264,003—and filed a separate complaint with the International Trade Commission (ITC), seeking an investigation into the same four patents. On August 27, 2024, the ITC announced it would institute a patent infringement investigation.Innoscience is also preparing to challenge the three German patents at issue and expressed confidence in its prospects for success.
![]() |
(Source: U.S. District Court for the Northern District of California) |
Comments
Post a Comment